Related Experiment Videos

[Changes of methicillin-resistant Staphylococcus aureus (MRSA) phagotypes in Gdansk in 1990-1998]

K Wiśniewska1, L Piechowicz, J Galiński

  • 1Katedra i Zakład Mikrobiologii Lekarskiej AM w Gdańsku.

Medycyna Doswiadczalna I Mikrobiologia
|April 5, 2001
PubMed

Insights

A new Methicillin-resistant Staphylococcus aureus (MRSA) phagotype, MR25/M5, emerged and predominated in Gdańsk hospitals between 1997-1998, showing multi-drug resistance. This new strain replaced previously common MRSA phagotypes, indicating a significant shift in circulating strains.

Area of Science:

  • Microbiology
  • Epidemiology
  • Infectious Diseases

Context:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat in hospital settings.
  • Monitoring the evolution and prevalence of MRSA strains is crucial for effective infection control.
  • Previous studies documented specific MRSA phagotypes in the Gdańsk region during the early 1990s.

Purpose:

  • To assess the changes in occurrence of various MRSA phagotypes in Gdańsk area hospitals from 1990 to 1998.
  • To characterize the drug resistance patterns of predominant MRSA strains.
  • To identify emerging MRSA strains and track the decline of previously common ones.

Summary:

  • The study analyzed 175 MRSA strains isolated between 1990-1998 from 18 hospitals in the Gdańsk area.
  • A new MRSA phagotype, MR25/M5, emerged and predominated (57.7%) in 1997-1998, exhibiting resistance to multiple antibiotics including doxycycline, gentamycin, and erythromycin.
  • Previously dominant phagotypes, such as MR8/MR12/MR25/30/33/38/M5/622, significantly decreased or disappeared, while MR25/M5 showed reduced susceptibility to fusidic acid.

Impact:

  • Identified the emergence and dominance of a new, multi-drug resistant MRSA phagotype (MR25/M5) in a specific geographic region.
  • Demonstrated a significant epidemiological shift in circulating MRSA strains over a decade.
  • Highlighted the changing susceptibility patterns of MRSA to antibiotics like fusidic acid, necessitating updated treatment guidelines.

Related Concept Videos